Loading...
Systemic immunosuppression in times of COVID‐19: Do we need to rethink our standards?
The current SARS‐CoV‐2 pandemic particularly endangers older people with pre‐existing cardiopulmonary and metabolic conditions. However, it is also currently under discussion whether patients under immunosuppressive therapy also have a higher risk of suffering a severe course of the COVID‐19 disease...
Saved in:
| Published in: | J Dtsch Dermatol Ges |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436367/ https://ncbi.nlm.nih.gov/pubmed/32743938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ddg.14194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|